Company Performance and Financials - American Well is expected to post a quarterly loss of $2 82 per share in its upcoming report representing a year-over-year change of +17 1% [2] - Revenues are expected to be $66 57 million down 5 8% from the year-ago quarter [2] - The consensus EPS estimate for the quarter has remained unchanged over the last 30 days [3] - American Well Corporation (AMWL) shares rallied 18 8% in the last trading session to close at $8 58 [5] Industry and Peer Comparison - American Well is part of the Zacks Medical Info Systems industry [3] - Standard BioTools (LAB) another stock in the same industry closed the last trading session 26 4% higher at $2 06 [3] - LAB has returned -14 7% in the past month [3] - For Standard BioTools the consensus EPS estimate for the upcoming report has remained unchanged over the past month at -$0 03 representing a change of +62 5% from what the company reported a year ago [4] Strategic Transactions - American Well sold its Amwell Psychiatric Care (APC) business to Avel eCare for approximately $21M in cash at closing and an additional earn-out payment [1] - The transaction will strengthen American Well's balance sheet while emphasizing the focus on growing accretive software contribution in the product mix [1]

Divestment of Amwell Psychiatric Care intended to focus product portfolio on key growth initiatives Company reiterates guidance for 2024 BOSTON, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a global leader in digital care, today announced it has sold its Amwell Psychiatric Care (APC) business to Avel eCare, a national leading provider of clinician-to-clinician telehealth services. With the divestiture of APC, a virtual psychiatric care service that Amwell purchased in 2019, Amwell continues to s ...

Core Insights - Amwell has announced that CFO Mark Hirschhorn will take on an expanded role as Chief Operating Officer effective January 1, 2025, reflecting the company's commitment to scaling its digital healthcare solutions [1][2] - Hirschhorn will oversee operational and growth strategies, including clinical, sales, and marketing teams, while maintaining his CFO responsibilities [2][3] - The company aims to achieve cash flow positivity by 2026, emphasizing a focus on operational efficiency and profitable growth [3] Leadership Changes - Two executives, Chief Commercial and Growth Officer Kathy Weiler and Chief Operating Officer Kurt Knight, will depart Amwell at the end of the year [2][4] - Weiler has significantly contributed to cost initiatives and the transformation of the growth organization, while Knight has played a key role in strategy, M&A, and scaling operations during the COVID-19 pandemic [2][4] Company Overview - Amwell is a leading hybrid care delivery platform in the U.S. and globally, connecting providers, payers, patients, and innovators to enhance access to affordable, high-quality care [5] - The company supports digital health needs across various care types, including urgent, acute, post-acute, chronic care management, and healthy living [5] - Amwell serves over 50 health plans, representing more than 100 million covered lives, and collaborates with many of the largest health systems in the nation [5]

American Well Corporation (NYSE:AMWL) Q3 2024 Earnings Conference Call October 30, 2024 5:00 PM ET Company Participants Sue Dooley - Head of Investor Relations Ido Schoenberg - Chairman and Chief Executive Officer Mark Hirschhorn - Chief Financial Officer Conference Call Participants Craig Hettenbach - Morgan Stanley Ryan MacDonald - Needham & Company Stan Berenshteyn - Wells Fargo Jailendra Singh - Truist Securities Charles Rhyee - TD Cowen Dave Larsen - BTIG Operator Ladies and gentlemen, good afternoon. ...

For the quarter ended September 2024, American Well Corporation (AMWL) reported revenue of $61.05 million, down 1.4% over the same period last year. EPS came in at -$2.87, compared to -$4.00 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of $62.06 million, representing a surprise of -1.64%. The company delivered an EPS surprise of +13.55%, with the consensus EPS estimate being -$3.32. While investors scrutinize revenue and earnings changes year-over-year and how they ...

American Well Corporation (AMWL) came out with a quarterly loss of $2.87 per share versus the Zacks Consensus Estimate of a loss of $3.32. This compares to loss of $4 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 13.55%. A quarter ago, it was expected that this company would post a loss of $3.94 per share when it actually produced a loss of $3.36, delivering a surprise of 14.72%. Over the last four quarters, the company has ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39515 American Well Corporation (Exact name of registrant as specified in its charter) Delaware 20-5009396 (State of incorpora ...

Exhibit 99.1 AMWELL ANNOUNCES RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2024 BOSTON, October 30, 2024 – Amwell ® (NYSE: AMWL), a leader in hybrid care enablement, today announced financial results for the third quarter of 2024. "Q3 was a busy quarter for Amwell as we steadily executed on key strategies that support our path to cash flow positive. We are aligning our cost structure to fit our strategy, with great emphasis on efficiency and effectiveness, while building our growth organization to deli ...

BOSTON, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leader in digital care, announced company leaders will participate in several upcoming investor conferences. Ido Schoenberg, M.D., Amwell chairman and chief executive officer, and Mark Hirschhorn, Amwell chief financial officer, will participate in fireside chats or one-on-one meetings at these events: Nov. 12: UBS Global Healthcare Conference in Palos Verdes, Calif. The fireside chat is at 8:45 a.m. PT.Nov. 20: Needham 4th Annual Consumer Te ...

American Well Corporation (AMWL) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2024. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.The earnings report, which is expected to be released on October 30, 2024, might help the stock move higher if these key numbers ...